Literature DB >> 7980113

Specific cleavage of a recombinant murine amelogenin at the carboxy-terminal region by a proteinase fraction isolated from developing bovine tooth enamel.

J Moradian-Oldak1, J P Simmer, P E Sarte, M Zeichner-David, A G Fincham.   

Abstract

A proteinase fraction of 48-70-kDa was isolated from developing bovine tooth enamel by size exclusion and reversed-phase high-pressure liquid chromatography (HPLC) techniques. Proteolytic activity in the HPLC fraction was visualized by enzymography using gelatin as substrate. A recombinant murine amelogenin (M179) composed of 179 amino acid residues (20 kDa) was used as a substrate to examine the specificity of the enzymes in the isolated fractions. Incubation of M179 with the proteinase fraction at 37 degrees C generated a major proteolytic product eluting at about 42% acetonitrile from the reversed-phase column. This product had an amino-terminal sequence Pro-Leu-Pro-Pro-His-Pro- in conformity with that of the M179 parent protein. These data indicated that the product resulted from the cleavage of the M179 recombinant protein in the carboxy-terminal region. Mass spectroscopic analysis of the product isolated by reversed-phase HPLC gave a molecular mass of 18.89 kDa. Given an intact amino-terminal sequence, this mass figure suggests that this product terminates at Pro168 of the M179 residue sequence. The presence of EDTA in proteolysis experiments when M179 was used as substrate inhibited production of the 18.89-kDa product. Antipain, aprotinin, leupeptin and 4,(amidinophenyl)methanesulphonyl fluoride, which are serine proteinase inhibitors, did not affect the proteolytic activity. In addition, replacement of Ca2+ with Zn2+, Mn2+ or Co2+ in the proteolysis buffer inhibited the enzymatic activity. It is concluded that the 'high molecular-weight' proteinase cleaving M179 at Pro168-Ala169 is a specific 'calcium-dependent metalloproteinase'.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7980113     DOI: 10.1016/0003-9969(94)90090-6

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  9 in total

Review 1.  MMPs and TIMPs--an historical perspective.

Authors:  J Frederick Woessner
Journal:  Mol Biotechnol       Date:  2002-09       Impact factor: 2.695

2.  Molecular evolution of amelogenin in mammals.

Authors:  Sidney Delgado; Marc Girondot; Jean-Yves Sire
Journal:  J Mol Evol       Date:  2005-01       Impact factor: 2.395

3.  Identification of a novel proteinase (ameloprotease-I) responsible for the complete degradation of amelogenin during enamel maturation.

Authors:  J Moradian-Oldak; W Leung; J P Simmer; M Zeichner-David; A G Fincham
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

4.  Immunoblotting studies on artifactual contamination of enamel homogenates by albumin and other proteins.

Authors:  W Y Chen; A Nanci; C E Smith
Journal:  Calcif Tissue Int       Date:  1995-08       Impact factor: 4.333

Review 5.  Role of matrix vesicles in biomineralization.

Authors:  Ellis E Golub
Journal:  Biochim Biophys Acta       Date:  2009-09-26

6.  Reduced amelogenin-MMP20 interactions in amelogenesis imperfecta.

Authors:  K Tanimoto; T Le; L Zhu; H E Witkowska; S Robinson; S Hall; P Hwang; P Denbesten; W Li
Journal:  J Dent Res       Date:  2008-05       Impact factor: 6.116

7.  Enamel matrix protein turnover during amelogenesis: basic biochemical properties of short-lived sulfated enamel proteins.

Authors:  C E Smith; W Y Chen; M Issid; A Fazel
Journal:  Calcif Tissue Int       Date:  1995-08       Impact factor: 4.333

8.  Enamel proteases reduce amelogenin-apatite binding.

Authors:  Z Sun; D Fan; Y Fan; C Du; J Moradian-Oldak
Journal:  J Dent Res       Date:  2008-12       Impact factor: 6.116

9.  Intrinsically disordered enamel matrix protein ameloblastin forms ribbon-like supramolecular structures via an N-terminal segment encoded by exon 5.

Authors:  Tomas Wald; Adriana Osickova; Miroslav Sulc; Oldrich Benada; Alena Semeradtova; Lenka Rezabkova; Vaclav Veverka; Lucie Bednarova; Jan Maly; Pavel Macek; Peter Sebo; Ivan Slaby; Jiri Vondrasek; Radim Osicka
Journal:  J Biol Chem       Date:  2013-06-19       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.